Program Overview

Small-cell lung cancer is a particularly deadly subtype of lung cancer, which accounts for approximately 15% of new lung cancer diagnoses. Unfortunately, nearly 60% of patients with SCLC present first with metastatic or extensive-stage (ES) disease, for whom standard of care therapy for nearly 40 years has been platinum doublet chemotherapy (cisplatin or carboplatin combined with etoposide or ...
View Course

Program Overview

This CME program, derived from content presented at the AACR Annual Meeting 2023 in Orlando, FL, will highlight the advancing role of PARP inhibitor combination therapies to improve outcomes for patients with metastatic castration-resistant prostate cancer (mCRPC). The expert faculty, led by Dr. Alan Tan, will first review the science, mechanism of action, and clinical rationale for PARP-inhibitors ...
View Course

Program Overview

While biosimilar therapeutics have been widely available for some time for the treatment inflammatory conditions, many pharmacists, managed care professionals, and other healthcare providers have not had a recent opportunity to investigate data showing the interchangeable safety and efficacy alignment between approved biosimilar therapeutics and their less accessible referent medications. In addition to interchangeability, concepts involving extrapolation and ...
View Course

Program Overview

This CME program, derived from content presented at the Pre-ACTRIMS Advanced Curriculum for Multiple Sclerosis 2023 CME Course in San Diego, California, will highlight new and emerging CD-20 targeted therapeutics for the treatment of patients with multiple sclerosis (MS). The expert faculty, Dr. Mark Freedman, will first review current clinical trial data for CD-20 targeted therapies to improve ...
View Course

Program Overview

Accurate diagnosis is vital for the successful management of patients with HCM.  Mistakes and delays in diagnosis are common. Hypertrophic cardiomyopathy commonly "masquerades" as asthma, anxiety, mitral prolapse, and coronary artery disease. However, once properly diagnosed, patients with HCM can be effectively managed to improve both symptoms and survival. Today, the diagnosis of HCM relies on the identification ...
View Course